ABO blood group and procoagulant factors: the hypercoagulation hypothesis ABO and Procoagulant Factors. Journal Article

Local Library Link: Find It @ Loyola

Authors: Lai, A; Jeske, W; Habeeb, O; Mooney, S; Levin, S; DeChristopher, PJ; Glynn, LA; Muraskas, JK
Article Title: ABO blood group and procoagulant factors: the hypercoagulation hypothesis ABO and Procoagulant Factors.
Abstract: BACKGROUND: The correlation between procoagulant levels-factor VIII (FVIII), von Willebrand factor (vWF), and fibrinogen-and risk of thrombosis has been well documented in adult populations. We hypothesize that interaction of passively transferred isoagglutinins in premature neonates with a compromised immune system may trigger an immune response that can target the immature gastrointestinal tract. The objective of this study is to evaluate if there are procoagulant level differences in preterm newborns stratified by ABO blood group. METHODS: VWF, FVIII, and fibrinogen levels were analyzed in neonates =32 weeks and/or birthweight =1500?g over the first 6 weeks of life. Demographic, blood type, and transfusion data were collected. RESULTS: Elevations in vWF and FVIII were found to be statistically significant in the third week of life in non-O neonates vs. type O neonates. FVIII was also found to be significantly elevated in week 1. Transfused neonates also showed elevations between weeks 0 and 3. CONCLUSION: There appears to be a time-dependent variation in procoagulant factor levels in preterm newborns. Although the clinical significance remains unclear, prothrombotic factors vWF and FVIII are significantly higher in non-O blood-type preterm neonates in the third week of life.
Journal Title: Pediatric Research
Publisher: Unknown  
Date Published: 2019